Clinical trial
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I…
NCT00008385 · ECOG-ACRIN Cancer Research Group, Other · Completed
Key facts
| NCT number | NCT00008385 |
|---|---|
| Title | Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer |
| Official title | Phase III Chemoprevention Trial Of Selenium Supplementation In Persons With Resected Stage I Non-Small Cell Lung Cancer |
| Lead sponsor | ECOG-ACRIN Cancer Research Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH SWOG Cancer Research Network North Central Cancer Treatment Group NCIC Clinical Trials Group Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Other |
| Interventions | placebo, selenium |
| Enrollment | 1,772 |
| Start date | Dec 18, 2000 |
| Primary completion | Jun 1, 2011 |
| Completion | Nov 1, 2019 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 5, 2023 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: